Loading...
A Review of Interstitial Pneumonitis Caused by Elotuzumab Through Case Discussions and Academic Writings
Patients with relapsed or refractory multiple myeloma have undergone two or three previous therapies are now being treated with a humanized IgG1 monoclonal antibody elotuzumab (HuLuc63) that targets F7 signalling lymphocytic activation molecule F7 (SLAMF7)- a signalling lymphocytic activation molecu...
Na minha lista:
| Udgivet i: | Cureus |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cureus
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686952/ https://ncbi.nlm.nih.gov/pubmed/33251069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.11162 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|